Intended Use

An over-the-counter software-only mobile medical application intended for users 22 years and older diagnosed with atrial fibrillation (AFib) that analyzes pulse rate data to identify irregular heart rhythms and estimate AFib burden.

Technology

The device uses photoplethysmography (PPG) sensor data collected by Apple Watch sensors to detect irregular heart rhythms consistent with AFib. It employs machine learning techniques, specifically a convolutional neural network, trained on extensive pulse data to classify rhythms and estimate AFib burden over specified time windows. The software is implemented as mobile apps on Apple Watch and iPhone, integrating with the Apple Health app to visualize data.

Performance

Performance validation included clinical and internal design control testing. The AFib History Feature's rhythm classification algorithm achieved 97% sensitivity and 99.0% specificity in development data and showed 92.6% sensitivity and 98.8% specificity in clinical validation with 413 participants. The feature accurately estimated AFib burden compared to ECG references, with most estimates within ±10% of reference values. Human factors testing confirmed safety and usability.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    12/20/2021

    5 months
  • 2

    FDA Approval

    6/3/2022

Other devices from Apple Inc.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.